Curative Biosciences Inc

Healthcare US CBDX

0.0001USD
0.00(0%)

Last update at 2026-06-02T20:00:00Z

Day Range

0.00010.0001

LowHigh

52 Week Range

0.00010.0002

LowHigh

Fundamentals

Previous Close 0.0001
Market Cap0.00316M
Volume600
P/E Ratio-
Dividend Yield-%
EBITDA-0.51549M
Revenue TTM0.00000M
Revenue Per Share TTM-
Gross Profit TTM 0.00000M
Diluted EPS TTM-

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2017-06-30	2016-06-30	2015-06-30	2014-06-30
Type	yearly	yearly	yearly	yearly
Date	2017-06-30	2016-06-30	2015-06-30	2014-06-30
Income before tax	-0.05319M	-1.65729M	-3.36858M	-29.99842M
Minority interest	-	-	-	-
Net income	-0.05319M	-1.65729M	-3.36858M	-29.99842M
Selling general administrative	0.05M	1.64M	1.70M	0.37M
Selling and marketing expenses	-	-	-	-
Gross profit	0.00000M	0.00000M	0.00000M	-0.05315M
Reconciled depreciation	0.00285M	-	-	-
Ebit	-0.05319M	-1.64116M	-1.70565M	-0.46866M
Ebitda	-0.05035M	-	-	-
Depreciation and amortization	-	-	-	-
Non operating income net other	-	-	-	-
Operating income	-0.05319M	-1.64116M	-1.70565M	-0.46866M
Other operating expenses	-	-	-	-
Interest expense	0.00000M	0.00000M	0.00000M	0.00000M
Tax provision	0.00000M	-	-	-
Interest income	-	-	-	-
Net interest income	-	-	-	-
Extraordinary items	-	-	-	-
Non recurring	-	-	0.20M	-
Other items	-	-	-	-
Income tax expense	0.00000M	0.00000M	0.00000M	0.00000M
Total revenue	0.00000M	0.00000M	0.00000M	0.00000M
Total operating expenses	0.05M	1.64M	1.71M	0.47M
Cost of revenue	0.00000M	0.00000M	0.00000M	0.05M
Total other income expense net	0.00000M	-0.01613M	-1.66294M	-29.52976M
Discontinued operations	-	-	-	-
Net income from continuing ops	-0.05319M	-1.65729M	-3.36858M	-29.99842M
Net income applicable to common shares	-0.05319M	-1.65729M	-3.36858M	-29.99842M
Preferred stock and other adjustments	-	-	-	-

Breakdown	2017-06-30	2016-06-30	2015-06-30	2014-06-30
Type	yearly	yearly	yearly	yearly
Date	2017-06-30	2016-06-30	2015-06-30	2014-06-30
Total assets	0.00227M	0.00511M	0.00996M	0.02M
Intangible assets	-	-	-	0.00125M
Earning assets	-	-	-	-
Other current assets	-	-	-	-
Total liab	0.63M	0.62M	0.71M	0.38M
Total stockholder equity	-0.63080M	-0.61511M	-0.69580M	-0.36579M
Deferred long term liab	-	-	-	-
Other current liab	0.38M	0.38M	0.38M	0.18M
Common stock	0.02M	0.02M	0.01M	0.00547M
Capital stock	-	-	-	-
Retained earnings	-53.16239M	-53.10919M	-51.45191M	-48.08332M
Other liab	-	-	-	-
Good will	-	-	-	-
Other assets	-	-	-	-
Cash	0.00000M	0.00000M	0.00200M	0.00181M
Cash and equivalents	-	-	-	-
Total current liabilities	0.63M	0.62M	0.71M	0.38M
Current deferred revenue	-	-	-	-
Net debt	-	-	-	-
Short term debt	0.06M	0.05M	0.02M	0.08M
Short long term debt	0.06M	0.05M	0.02M	0.08M
Short long term debt total	-	-	-	-
Other stockholder equity	-	-	-	-
Property plant equipment	0.00227M	0.00511M	0.00796M	0.01M
Total current assets	0.00000M	0.00000M	0.00200M	0.00359M
Long term investments	-	-	-	-
Net tangible assets	-0.63080M	-0.61511M	-0.69580M	-0.36704M
Short term investments	-	-	-	0.00178M
Net receivables	-	-	-	-
Long term debt	-	-	-	-
Inventory	-	-	-	-
Accounts payable	0.18M	0.18M	0.13M	0.04M
Total permanent equity	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-
Accumulated other comprehensive income	-	-	-	-
Additional paid in capital	-	-	-	-
Common stock total equity	-	-	-	-
Preferred stock total equity	-	-	-	-
Retained earnings total equity	-	-	-	-
Treasury stock	-	-	-	-
Accumulated amortization	-	-	-	-
Non currrent assets other	0.00227M	0.00511M	-	-
Deferred long term asset charges	-	-	-	-
Non current assets total	0.00227M	0.00511M	-	-
Capital lease obligations	0.18M	-	-	-
Long term debt total	-	-	-	-

Breakdown	2017-06-30	2016-06-30	2015-06-30	2014-06-30
Type	yearly	yearly	yearly	yearly
Date	2017-06-30	2016-06-30	2015-06-30	2014-06-30
Investments	0.00000M	0.00000M	-	-
Change to liabilities	0.00005M	0.04M	0.09M	0.17M
Total cashflows from investing activities	-	-	-	-
Net borrowings	0.01M	0.03M	0.07M	0.14M
Total cash from financing activities	0.01M	0.03M	0.07M	0.14M
Change to operating activities	-	-0.15750M	0.30M	0.08M
Net income	-0.05319M	-1.65729M	-3.36858M	-29.99842M
Change in cash	0.00000M	-0.00200M	0.00019M	0.00019M
Begin period cash flow	0.00000M	-	-	-
End period cash flow	0.00000M	-	-	-
Total cash from operating activities	-0.01280M	-0.02900M	-0.06535M	-0.14428M
Issuance of capital stock	-	-	-	-
Depreciation	0.00285M	0.00285M	0.00410M	0.04M
Other cashflows from investing activities	-	-	-	-
Dividends paid	-	-	-	-
Change to inventory	-	-	-	0.05M
Change to account receivables	-	-	-	-
Sale purchase of stock	-	-	-	-
Other cashflows from financing activities	-	-	-	-
Change to netincome	0.04M	1.74M	2.91M	29.51M
Capital expenditures	0.00000M	0.00000M	0.00000M	0.00000M
Change receivables	-	-	-	-
Cash flows other operating	-	-	-	-
Exchange rate changes	-	-	-	-
Cash and cash equivalents changes	-	-	-	-
Change in working capital	0.00005M	-	-	-
Stock based compensation	-	-	-	-
Other non cash items	0.04M	-	-	-
Free cash flow	-0.01280M	-	-	-

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to EBITDA (x)
CBDX Curative Biosciences Inc	- -%	0.0001	-	-	-	-	-18.7699
ZTS Zoetis Inc	1.20 1.57%	77.59	40.18	30.96	10.67	17.60	11.27	26.18
MKKGY Merck KGaA ADR	0.58 1.91%	31.01	21.25	14.93	3.10	2.14	3.60	12.98
MKGAF MERCK Kommanditgesellschaft auf Aktien	- -%	153.91	21.73	14.95	3.16	2.15	3.56	12.82
GALDY GALDERMA GROUP AG	-0.79 1.89%	40.92	74.21	41.67	8.64	5.55	9.15	42.22

Reports Covered

View All

Profile

Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.

Curative Biosciences Inc

801 Brickell Avenue, Miami, FL, United States, 33131

https://curativebio.com

Key Executives

Name	Title	Year Born
Mr. Richard Damion	Chairman & CEO	1943
Mr. A. R. Grandsaert	Pres	1943
Mr. William Lindberg	CFO & Director	1933
Ms. Katherine T. Alverson West	Exec. VP, Sec. & Director	1970
Mr. A. R. Grandsaert	President	1943
Ms. Katherine T. Alverson West	Executive VP, Secretary & Director	1970
Ms. Katherine T. Alverson West	Executive VP & Secretary	1970

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.